U.S. Supreme Court Supports FDA Decision on E-Cigarette Regulation

Apr.03.2025
U.S. Supreme Court Supports FDA Decision on E-Cigarette Regulation
US Supreme Court supports FDA decision to reject sales of flavored e-cigarette products, emphasizing protection of youth from nicotine risks.

Key Points:

The Supreme Court of the United States has upheld the FDA's decision to reject the sale of flavored e-cigarette products by Triton Distribution and Vapetasia, stating that the FDA followed legal procedures outlined in the Administrative Procedure Act.

The ruling emphasizes the protection of young people from the nicotine addiction risks associated with flavored e-cigarettes, and supports the FDA's measures to protect the health of teenagers.

The court confirmed that the FDA did not act improperly in evaluating applications, standards, and scientific evidence, despite e-cigarette companies claiming that their products have harm reduction potential for traditional smokers.


According to a report by Reuters on April 3, the US Supreme Court strongly supported the US Food and Drug Administration's (FDA) decision to deny two e-cigarette companies from selling flavored e-cigarette products, which regulatory agencies believe pose a risk to the health of young people.

 

Supreme Court Justice Samuel Alito wrote a decision unanimously overturning a lower court's ruling. The lower court had previously determined that the FDA did not follow legal procedures outlined in the Administrative Procedure Act when denying applications from Triton Distribution and Vapetasia to sell nicotine-containing products.

 

The two e-cigarette companies claim that the regulatory standards used by the FDA in assessing their applications do not align with the published guidelines they rely on. Alito pointed out in the ruling that "stakeholders may believe that the agency will apply a less stringent evidence standard than what is ultimately outlined in the FDA's denial order." Alito stated that...

 

In the end, we cannot say that the FDA has inappropriately changed its stance on scientific evidence and other guidelines.

 

This ruling did not address the FDA's failure to consider the harmful effects of its restrictions on minors accessing and using its product plans, and ordered lower courts to re-evaluate the issue according to different legal standards.

 

The Tobacco-Free Kids organization has expressed appreciation for the Supreme Court's ruling, stating that the decision "should encourage the FDA to maintain its current regulatory direction." The organization stated in a release, "Today's ruling is an important victory for the health of American children and protecting them from efforts to lure them into the youth nicotine addiction crisis posed by flavored e-cigarettes.

 

In 2016, during President Barack Obama's term, the FDA classified e-cigarettes as tobacco products, requiring them to be regulated under the 2009 Tobacco Control Act.

 

For years, the FDA has only approved 34 flavored e-cigarette products, all of which are tobacco or mint flavors. The agency insists that it has not completely banned flavored e-cigarette products. Despite being illegal, various flavored e-cigarette products are still easily accessible. In order to obtain regulatory approval, e-cigarette companies must prove that their products are "appropriate for protecting public health," which means that any health benefits (such as helping traditional cigarette smokers transition to less harmful e-cigarettes) must outweigh the risks of introducing a new product to the market.

 

Eric Heyer, the lawyer for the e-cigarette company, expressed disappointment with the court's ruling. "Triton and Vapetasia continue to believe in the potential of their products to reduce harm for smokers.

 

Triton Distribution and Vapetasia applied for FDA approval for their products in 2020, which include flavors such as sour grape, pink lemonade, and vanilla pudding, as well as names like "Jimmy The Juice Man Peachy Strawberry" and "Suicide Bunny Mother's Milk and Cookies." These products have been criticized for being designed to attract minors, and the FDA rejected applications for over a million flavored e-cigarette products, including those from Triton and Vapetasia.

 

During the trial on December 2nd, the Justice Department lawyer representing the FDA stated that e-cigarette companies were aware throughout the application process of the agency's concerns regarding flavors that attract young people and the harmful nature of nicotine on the developing adolescent brain.

 

During the debate, Hill hinted that President Donald Trump's administration may change the US government's stance on flavored e-cigarette products. Despite previously supporting a ban on flavored e-cigarette products in his first term, Trump promised to "save e-cigarettes" during his presidential campaign.

 

The FDA found in 2020 that nearly one-fifth of high school students and nearly one-twentieth of middle school students were using e-cigarettes, making e-cigarettes the "most widely used tobacco product among youth." Triton and Vapetasia requested a review of the FDA's denial of their applications at the Fifth Circuit Court of Appeals in New Orleans in 2021. The full panel of judges at the Fifth Circuit ruled 10-6 that the FDA violated the Administrative Procedure Act, acting arbitrarily and capriciously, while seven other federal appellate courts supported the FDA in similar cases.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Posts Final ZYN MRTP Materials, Sets March 4 Deadline for Public Comments
U.S. FDA Posts Final ZYN MRTP Materials, Sets March 4 Deadline for Public Comments
U.S. FDA has released the final batch of materials for ZYN MRTP applications and set March 4 (11:59 p.m. ET) as the deadline for public comments to be considered in the agency’s review.
Feb.03 by 2FIRSTS.ai
China’s Tobacco Regulator Moves to Introduce Credit Management Framework for E-Cigarette Manufacturers, Greater Transparency May Improve International Assessability of China’s Supply Chain
China’s Tobacco Regulator Moves to Introduce Credit Management Framework for E-Cigarette Manufacturers, Greater Transparency May Improve International Assessability of China’s Supply Chain
China’s tobacco regulator has moved to introduce a credit management framework for e-cigarette manufacturers, outlining a system that links compliance records to regulatory oversight. The proposal forms part of a broader push to institutionalize supervision and improve transparency across China’s e-cigarette supply chain.
Jan.05
Charlie’s Holdings Signs Licensing Agreement with IKE Tech to Commercialize Age-Gated Vape Technology in the U.S.
Charlie’s Holdings Signs Licensing Agreement with IKE Tech to Commercialize Age-Gated Vape Technology in the U.S.
Charlie’s Holdings has signed a licensing agreement with IKE Tech to commercialize an age-gated vape activation system in the U.S. The technology combines biometric authentication, BLE hardware, and a mobile app for continuous device-level age verification. The company plans to test-market the system with SBX nicotine analogue products this spring and may later apply it to PACHA-branded ENDS.
News
Jan.06
FDA schedules online roundtable to gather small manufacturers’ input on ENDS PMTA requirements
FDA schedules online roundtable to gather small manufacturers’ input on ENDS PMTA requirements
FDA announced it will convene a Feb. 10, 2026 roundtable with small tobacco product manufacturers to gather feedback on PMTA submissions for ENDS products. The discussion will be viewable online, and a public docket is open for comments through March 12, 2026.
Feb.10 by 2FIRSTS.ai
Product | Unique Serial Number + Custom Design: Vuse Launches McLaren F1 Team Limited-Edition Vape
Product | Unique Serial Number + Custom Design: Vuse Launches McLaren F1 Team Limited-Edition Vape
Vuse has launched a McLaren Racing co-branded limited-edition vape, the Vuse Ultra x McLaren F1 Team Limited Edition, on its official website. Based on the standard Vuse Ultra, the device features design elements including McLaren’s “Racing Papaya” orange, and comes with wireless charging and two replaceable batteries. The product is priced at £45.
Dec.18 by 2FIRSTS.ai
Special Report|Russia scales back anti-vaping drive, limits ban to single-region trial
Special Report|Russia scales back anti-vaping drive, limits ban to single-region trial
After months of debate, Russian lawmakers have retreated from plans for a nationwide vaping ban, opting instead for a single-region pilot. The shift reflects pressure from business groups and fiscal authorities, amid warnings that sweeping prohibitions could fuel illegal trade while undermining efforts to regulate the market.
Jan.22